Correlation Between Vivos Therapeutics and Pulmatrix

Can any of the company-specific risk be diversified away by investing in both Vivos Therapeutics and Pulmatrix at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vivos Therapeutics and Pulmatrix into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Vivos Therapeutics and Pulmatrix, you can compare the effects of market volatilities on Vivos Therapeutics and Pulmatrix and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vivos Therapeutics with a short position of Pulmatrix. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vivos Therapeutics and Pulmatrix.

Diversification Opportunities for Vivos Therapeutics and Pulmatrix

-0.06

Correlation Coefficient

Vivos Therapeutics  Pulmatrix

Good diversification

The 3 months correlation between Vivos and Pulmatrix is -0.06. Overlapping area represents the amount of risk that can be diversified away by holding Vivos Therapeutics and Pulmatrix in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pulmatrix and Vivos Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vivos Therapeutics are associated (or correlated) with Pulmatrix. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pulmatrix has no effect on the direction of Vivos Therapeutics i.e., Vivos Therapeutics and Pulmatrix go up and down completely randomly.

Pair Corralation between Vivos Therapeutics and Pulmatrix

Given the investment horizon of 90 days Vivos Therapeutics is expected to under-perform the Pulmatrix. In addition to that, Vivos Therapeutics is 1.48 times more volatile than Pulmatrix. It trades about -0.16 of its total potential returns per unit of risk. Pulmatrix is currently generating about 0.0 per unit of volatility. If you would invest  500.00  in Pulmatrix on August 10, 2025 and sell it today you would lose (15.00) from holding Pulmatrix or give up 3.0% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Vivos Therapeutics  vs.  Pulmatrix

Vivos Therapeutics

Risk-Adjusted Performance

Weakest

Over the last 90 days Vivos Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in December 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Pulmatrix

Risk-Adjusted Performance

Weakest

Over the last 90 days Pulmatrix has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy essential indicators, Pulmatrix is not utilizing all of its potentials. The current stock price disarray, may contribute to short-term losses for the investors.

Pair Trading with Vivos Therapeutics and Pulmatrix

The main advantage of trading using opposite Vivos Therapeutics and Pulmatrix positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vivos Therapeutics position performs unexpectedly, Pulmatrix can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pulmatrix will offset losses from the drop in Pulmatrix's long position.

The idea behind Vivos Therapeutics and Pulmatrix pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.